Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Named profile Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted TherapyRepresentative category illustration – no product packaging is shown.Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted Therapy
Palladia is an FDA-approved prescription veterinary tyrosine kinase inhibitor for treatment of Patnaik grade II or III recurrent canine cutaneous mast cell tumors, with or without regional lymph-node…
Read more
Named profile Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine LymphomaRepresentative category illustration – no product packaging is shown.Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine Lymphoma
Verdinexor is an oral prescription antineoplastic for certain dogs with lymphoma. FDA announced full approval in January 2026 after the product's earlier conditional-approval pathway; publication should use the…
Read more
Histopathology: Tumor Type, Grade, and Surgical Margins
Histopathology examines fixed tissue architecture and usually provides more specific tumor classification than cytology. Depending on tumor type and specimen, the report may include grade, mitotic activity, invasion,…
Read more
Multimodal Pain Management in Canine Cancer Care
Multimodal pain management combines approaches that act at different points in the pain pathway and addresses both the tumor and its functional consequences. A plan may include prescriptions,…
Read more
Antiemetic Support During Canine Cancer Treatment
Antiemetic therapy aims to prevent or control nausea and vomiting from chemotherapy, radiation fields, anesthesia, medications, the tumor, or another disease. Drug choice and timing depend on the…
Read more
Appetite Support: Find and Treat the Reason a Dog Is Not Eating
Reduced appetite can result from nausea, pain, fever, constipation, oral disease, swallowing difficulty, medication effects, tumor location, stress, or metabolic illness. Appetite support starts by investigating and treating…
Read more
Veterinary Rehabilitation During and After Cancer Care
Veterinary rehabilitation uses a medically supervised assessment and individualized plan to address pain, weakness, mobility limits, deconditioning, and functional goals. In oncology it must be coordinated with the…
Read more
Maropitant for Nausea and Vomiting Support in Cancer Care
Maropitant is a prescription antiemetic used for selected dogs and cats, but controlling vomiting does not identify or resolve every cause of nausea or gastrointestinal disease.
Read more
Ondansetron for Persistent Nausea: Role and Interaction Review
Ondansetron is a serotonin-receptor antiemetic used by veterinarians for selected nausea and vomiting, often when one pathway or medicine is not enough.
Read more
Metoclopramide: Antiemetic and Motility Questions in Oncology
Metoclopramide has antiemetic and upper-gastrointestinal motility effects, making obstruction, neurologic history, cause, route, and interactions central to safe selection.
Read more
Mirtazapine for Appetite Support: Nausea-First and Interaction Boundary
Mirtazapine may support appetite in selected dogs or cats, but nausea, pain, obstruction, oral disease, diet, organ function, and serotonergic interactions need attention first.
Read more
Veterinary NSAIDs in Oncology: Pain, Inflammation, and Interaction Safety
A veterinary NSAID may support pain and inflammation and has tumor-specific roles in selected plans, but the exact product, species label, organ risk, and drug combinations govern safety.
Read more